RxDoctor Payments Data

Kari Sears, MD

Family Medicine · South Bend, INNPI 1548556111

Payments from drug & device makers

$1,556in general payments, 2019–2025

Across 94 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$352
  • AstraZeneca$259
  • Novo Nordisk$158
  • AbbVie$156
  • Johnson & Johnson$77
  • Abbott$72
  • plus $482 from 19 others

What the payments were for

  • Food & beverage$1,556100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,556 in reported general payments places this provider in the 65th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$89,712
Medicare patients
323
Services billed
1,264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$97,591
JardianceEmpagliflozin59$61,690
EliquisApixaban44$31,492
RybelsusSemaglutide21$28,669
MounjaroTirzepatide26$27,518
TrulicityDulaglutide18$21,794
JanuviaSitagliptin Phosphate20$16,221
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$15,100
NucyntaTapentadol Hcl12$13,954
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$11,837
Breo ElliptaFluticasone/Vilanterol11$11,106
XareltoRivaroxaban13$9,639
FarxigaDapagliflozin Propanediol17$6,771
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$6,075
MyrbetriqMirabegron24$5,725

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$158$126,25981 claims
Lilly USA, LLCMounjaro, Trulicity$23$49,31244 claims
PfizerEliquis$352$31,49244 claims
MerckJanuvia$47$16,22120 claims
Johnson & JohnsonXarelto$77$9,63913 claims
AstraZenecaFarxiga$259$6,77117 claims
AbbVieSynthroid$156$3,91166 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in South Bend

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →